CTRI/2021/10/037538尚未招募2 期
A PROSPECTIVE STUDY OF CHEMOTHERAPY FOLLOWED BY STEREOTACTIC BODY RADIATION THERAPY(SBRT) IN BORDERLINE RESECTABLE PANCREATIC CANCER(BRPC) AND LOCALLY ADVANCED PANCREATIC CANCER (LAPC)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histologically confirmed adenocarcinoma of pancreas
- •2. Determined borderline resectable or locally advanced.
- •3. Induction modified FOLFIRINOX/ Gemcitabine based combination/ Gemcitabine-nab paclitaxel up to 3cycles.
- •4. Stable or disease regression on re staging scans.
- •5. Tumour diameter 7 cm
- •6. Satisfying the radiation normal tissue constraints as per protocol.
- •7. ECOG 0,1,2
- •8. Patients must have acceptable organ and marrow function:
- •9. Ability to understand and willingness to sign an informed consent.
排除标准
- •1.Tumor in growth into stomach or duodenum
- •2.Metastatic disease
- •3. Patients who have had prior radiotherapy to upper abdomen/liver.
- •4. Patients who have received prior chemotherapy for pancreatic cancer, other than Gemcitabine/ nab paclitaxel/ FOLFIRINOX
- •5. Uncontrolled intercurrent illness including but not limited to ongoing iOS active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia,or psychiatric illness/ social situations that would limit compliance with study requirements.
研究者
相似试验
进行中（未招募）
不适用
Observational study in Breast cancer patient who are taking Anthracyclin Chemotherapy to observe chemotherapy induced nausea and vomitingCTRI/2016/01/006555Tata Memorial Centre
撤回
不适用
Control of emesis in R-CHOP (Rituximab (R) - Cyclophosphamide (C), Doxorubicin (H), Vincristine (O), Prednisolone (P)ACTRN12611001269921Australasian Leukaemia and Lymphoma Group100
已完成
不适用
A prospective study of the effect of chemotherapy on metabolic and cardiovascular function in women with early stage breast cancerEarly stage breast cancerCancer - BreastACTRN12614001055695A/Prof Bogda Koczwara29
已完成
不适用
The study of the response to the chemotherapy using S-1 and CDGP for p16 positive/p53 negative oropharnygeal squamous cell carcinomaoropharyngeal squamous cell carcinomaJPRN-UMIN000024707Kobe City Medical Center General Hospital, Head and Neck Department50
已完成
不适用
RANDOMIZED STUDY OF COADYUVANT CHEMOTHERAPY WITH STANDARD REGIMES OF CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUORURACILO - (CMF) OR DOXORUBICINE AND CICLOFOSFAMIDA - (AC) VERSUS CAPECITABINE IN WOMEN 65 YEARS OF AGE OR MORE POSITIVE OR NEGATIVE NODULES WITH HIGH-RISK BREAST CANCER.-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-100-03EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),